Inactivation of splicing factors in HeLa cells subjected to heat shock. by Shukla, R R et al.
THE JOURNAL OF BIOLOCKXL CHEMISTRY Vol. 265, No. 33, Issue of November 25. pp. 20377-20383, 1990 
Cc) 1990 by The American Society for Biochemistry end Molecular Biology, Inc. Printed in U.S.A. 
Inactivation of Splicing Factors in HeLa Cells Subjected to 
Heat Shock* 
(Received for publication, June 14, 1990) 
Ram R. Shukla, Zbigniew Dominski, Tadeusz ZwierzynskiS, and Ryszard Kole§ 
From the Department of Pharmacology and Lineberger Cancer Research Center, University of North Carolina, 
Chapel Hill, North Carolina 27599 
The nuclear extracts from HeLa cells subjected to 
heat shock at 43 or 46 “C for 2 h were unable to splice 
pre-mRNA in uitro. Analysis of snRNPs in the extracts 
revealed that the U4 f U5. U6 small nuclear ribonucle- 
oprotein particle (snRNP) complex was disrupted at 
both temperatures while Ul and U2 snRNPs remained 
unaffected at 43 “C but were disrupted to certain ex- 
tent during heat shock at 46 “C. During splicing reac- 
tion, the extract from cells heat shocked at 43 “C 
formed intermediate splicing complexes (Y and fi but 
was unable to form a functional spliceosome, complex 
y. Addition of fractions from a normal nuclear extract 
restored splicing activity only in the extract from cells 
subjected to heat shock at 43 “C. Using this comple- 
mentation assay, we have partially purified the fac- 
tor(s) inactivated at this temperature. The purified 
factor(s) was essentially devoid of snRNAs and snRNPs 
and resistant to micrococcal nuclease, indicating that 
the factor(s) inactivated by in uiuo heat shock at 43 “C 
is a protein. 
We have also subjected the nuclear extracts from 
normal HeLa cells to in vitro heat treatment at 43 or 
46 “C. The results indicate that during in vitro heat 
treatment of the extracts the damage to splicing ma- 
chinery is more extensive than that during in uiuo heat 
shock. These experiments also suggest that the fac- 
tor(s) inactivated by heat shock at 43 “C is different 
from previously identified thermolabile splicing fac- 
tors. 
The response of cells to a number of environmental stresses 
results in the increased intracellular level of proteins termed 
heat shock proteins (hsps).’ This response is elicited by heat 
as well as by a number of chemicals, such as ethanol, sodium 
arsenite, and heavy metals, and could be seen in all organisms 
examined, from Escherichia coli to man (l-3). Heat shock 
genes can also be activated either by denatured (4) or modified 
proteins (5). In addition to heat shock proteins, other proteins 
can be induced during stress response. These include ubiquitin 
(6, 7) metalloproteinases (8), and heme oxygenase (9). Other 
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reported effects of heat shock include alteration in antigenic 
reactivity of hnRNPs (Ref. 10 and references cited therein) 
and snRPNs (11). 
Induction of heat shock proteins is always accompanied by 
a significant decrease in the synthesis of other proteins. The 
mechanism of suppression is not well understood. Inhibition 
of translation seems to be at least partially responsible, pos- 
sibly via phosphorylation of initiation factors (12). Earlier 
studies of heat shock in Drosophila suggested inhibition of 
transcription of mRNA coding for non-heat shock proteins 
(reviewed in Ref. 13). In contrast, recent studies have shown 
that heat shock of HeLa cells does not affect the rate of 
mRNA transcription but nevertheless lowers the concentra- 
tion of non-hsp mRNA in the cytoplasm (14). The latter 
finding indicates that post-transcriptional events, such as 
inhibition of pre-mRNA splicing or nuclear transport may be 
responsible for this result. Since the majority of heat shock 
genes do not contain introns, inhibition of pre-mRNA splicing 
would provide a potential mechanism of discrimination be- 
tween heat shock-inducible and non-heat shock transcripts. 
Indeed, it has been shown that in uivo splicing of pre-mRNA 
was inhibited during heat shock of Drosophila (15, 16) or 
mammalian cells (7, 17, 18). 
It seems likely that inhibition of splicing during heat shock 
is caused by inactivation of certain components of the splicing 
machinery. If this is the case, one should be able to study the 
mechanism of inactivation and identify the factors damaged 
by heat shock using an in vitro splicing system. We report 
here that nuclear extracts from HeLa cells subjected to heat 
shock are not able to splice mRNA precursors. The splicing 
activity can be rescued by chromatographically purified frac- 
tions of nuclear extracts from untreated cells suggesting that 
a specific thermolabile splicing factor is inactivated by heat 
shock. Our results indicate that the inactivated factor is 
different from other known splicing factors. 
EXPERIMENTAL PROCEDURES 
Cell culture-HeLa cells were grown in suspension in Joklik’s 
modified minimal Eagle’s medium containing kanamycin and genta- 
mycin, supplemented with 10% calf serum (Hyclone Labs). For heat 
shock experiments the cells were pelleted (1000 x g, 10 min), resus- 
pended in medium prewarmed to 43 “C (half of the original volume), 
and incubated at this temperature for 2 h. Immediately thereafter the 
cells were pelleted, washed with ice-cold phosphate-buffered saline, 
and nuclear extracts were prepared (see below). For recovery experi- 
ments heat shocked cells were pelleted, resuspended in a medium 
prewarmed to 37 “C, and nuclear extracts were prepared at specified 
times (see Fig. 1C). Cell survival was assayed by trypan blue exclusion. 
Preparation of the Nuclear and Cytoplasmic (5’100) Extracts- 
Splicing nuclear extract was prepared essentially according to Dignam 
et al. (19) and Krainer et al. (20) except that nuclei were subjected to 
an additional wash with buffer A (10 mM Hepes, pH 7.9, 1.5 mM 
MgC12, 10 InM KCl, and 0.5 mM dithiothreitol; see Ref. 19). The 
cytoplasmic S-100 fraction was prepared and concentrated by precip- 
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itation with ammonium sulfate as described by Hernandez and Keller 
(21). 
Fractionation of the Nuclear Extract-Nuclear extract from 1.2 x 
IO’” cells (approximately 10 ml) obtained as described above was 
dialyzed for 5 h against buffer D (19) supplemented with 12.5 mM 
MgCl, so that the final composition of the dialysis buffer was: 20 mM 
Hepes, pH 7.9, 20% glycerol, 0.1 M KCl, 0.5 mM dithiothreitol, and 
12.5 mM MgCln. After dialysis the extract was centrifuged for 30 min 
at 16,000 rprn in Sorvall SS34 rotor. The resultant pellet, referred to 
as the “magnesium pellet,” was resuspended in 10 ml of buffer D and 
loaded onto a fast protein liquid chromatography Mono Q (HR 5/5) 
column preequilibrated with buffer D containing 10% glycerol. The 
column was washed with 5 bed volumes of the same buffer and eluted, 
in l-ml fractions, with the same buffer containing 0.5 M KCl. Activity 
peak was pooled, dialyzed against buffer D, and reloaded onto a Mono 
Q column. The column was washed with buffer D containing 10% 
glycerol and eluted with a linear gradient of 0.1-0.5 M KC1 in the 
same buffer. 3-ml fractions were dialyzed against buffer D and con- 
centrated approximately 5-fold by treating the dialysis bags with dry 
Sephadex G-200. Concentrated fractions were aliquoted and stored 
at -70 “C. Protein concentration in the fractions was assayed with a 
Bio-Rad reagent following manufacturers protocol. 
Analysis of snRNPs in Nuclear Extracts-l-p1 aliquots of nuclear 
extracts, containing approximately 3 fig of protein, were electropho- 
resed on 4.5% nondenaturing polyacrylamide gels as described (22). 
The separated material was electroblotted onto nylon membranes 
(GeneScreen) and hvbridized to 32P-labeled RNA probes for Ul. U2, 
U4, U5, and U6 snRNAs. The probes were obtained by in bitro 
transcription of plasmids carrying anti-U-RNA sequences fused to 
SP6 promoter. The plasmids were a kind gift of Drs. U. Bond and J. 
Steitz (Yale University). 
Analysis of Spliceosome Formation-Aliquots (1 ~1) of standard 
splicing reaction were separated on nondenaturing polyacrylamide 
gel as described (22) except that the concentration of polyacrylamide 
was lowered to 3.8%. For analysis of spliced products and interme- 
diates in the spliceosome complexes, appropriate bands were excised 
from the gel, eluted, and the RNA analyzed on sequencing polyacryl- 
amide gels (23). 
Analysis of RNA from Nuclear Extracts and Column Fractions- 
Aliquots of the nuclear extract or column fractions were extracted 
with phenol and precipitated with ethanol. The RNA was electropho- 
resed on a 12.5% polyacrylamide, 7 M urea sequencing gel (20 X 40 X 
0.04 cm), and the gel was stained with silver (Gelcode, Pierce Chem- 
ical Co.). As little as 3 ~1 of the extract is sufficient to visualize the 
RNA by this procedure. 
Transcription of pSP64HBA6 Template and Splicing-These re- 
actions were carried out according to published procedures (24-26). 
In all experiments, a “‘P-labeled human p-globin transcript was 
obtained by SP6 RNA polymerase transcription of the plasmid 
pSP64HBA6 linearized within the second exon at the BamHI restric- 
tion site. In the standard splicing assay, a 25-~1 reaction mixture 
contained 15 ~1 of extract. In the complementation assays, tested 
fractions (usually 3-5 bl), normalized to equal amount of protein, 
were added to the standard reaction mixture containing lo-12 ~1 of 
the nuclear extract. All the splicing reactions were carried out at 
30 “C for 90 min, unless indicated otherwise. The RNA from the 
reaction was isolated by phenol extraction and ethanol precipitation 
and separated by electrophoresis on an 8% polyacrylamide sequencing 
gel. 
Digestion of snRNPs with Micrococcal Nucleose-The extract or 
purified fractions were treated with 600 units/ml of micrococcal 
nuclease (Boehringer Mannheim) in the presence of 1 mM Ca*+ as 
described elsewhere (25). After removal of calcium with 4 mM EGTA, 
nuclease-treated material was used in complementation assays as 
described above. 
RESULTS 
Inactivation of Splicing Activity in Nuclear Extracts from 
Heat-shocked Cells-To examine the effect of heat shock on 
pre-mRNA splicing, we have subjected HeLa cells to heat 
shock under various conditions and prepared nuclear extracts 
from these cells immediately thereafter. The extracts were 
tested in the in vitro splicing assay with human P-globin pre- 
mRNA as substrate. The RNA was analyzed on an 8% poly- 
acrylamide sequencing gel. The intermediates and products 
of splicing were identified on the basis of their mobility on 
the gel and previous characterization (26, 27). 
The effects of the 2-h heat shock of HeLa cells at 40,43, or 
46 “C on the splicing activity of the extracts is shown in Fig. 
lA. Extract obtained after 40 “C treatment retained full splic- 
ing activity (lane Z), as compared with control extract (lane 
1), whereas heat shock of cells at 43 or 46 “C completely 
abolished the splicing activity (lanes 4 and 6, respectively). If 
the activation of splicing is caused by the damage of specific 
splicing factors and not pleiotropic heat denaturation of a 
large number of proteins, one should be able to rescue the 
splicing activity by complementation of the inactive extract 
with fractions of splicing extracts from untreated cells. As 
can be seen from the figure, the nuclear extract from cells 
heat shocked at 43 “C was reactivated by a fraction of the 
extract from untreated cells (lane 5), whereas the extract from 
cells heat-shocked at 46 “C was not (lane 7). The fraction 
alone is inactive in splicing (lane 8). This fraction, termed 
the magnesium pellet (see “Experimental Procedures” and 
below), is enriched in snRNPs and contains approximately 
10% of extract proteins. Thus, it appears that heat shock at 
43 “C caused less extensive damage to splicing machinery 
than heat shock at 46 “C. Additional support for this conclu- 
sion is provided by the following findings. First, heat shock 
of HeLa cells for at least 1 h at 43 “C is necessary for 
inactivation of splicing (Fig. lB, lane 3), but even after 4 h at 
this temperature, the nuclear extracts from treated cells could 
be rescued by the magnesium pellet (Fig. lB, lane 10). Essen- 
tially the same results were obtained with fractions of much 
higher purity after column chromatography (see below, Fig. 
6A). Second, splicing activity was recovered within 2 h after 
the cells were returned to normal growing conditions at 37 “C 
(Fig. lC), and no apparent cell death was detected by trypan 
blue exclusion (not shown). 
To ascertain that the lack of splicing activity in the nuclear 
extract from heat-shocked cells was due to inactivation of the 
factor(s) rather than its excessive leakage from the nuclei to 
the cytoplasm, we have supplemented the extract with the 
cytoplasmic, S-100, fraction from normal or heat shocked 
cells. The S-100 fraction from untreated cells rescued the 
splicing activity in this assay, as could be expected since a 
number of splicing factors leaks out to the cytoplasm during 
preparation of the extract (25). In contrast, the S-100 from 
cells heat-shocked at 43 “C did not reactivate the extract 
suggesting that the factor(s) required for activity is inactive 
in both cytoplasmic and nuclear fractions (not shown). 
Inactivation of Splicing in Heat-treated Nuclear Extracts- 
To compare loss of splicing activity during in uiuo heat shock 
of cells versus in vitro heat treatment of the nuclear extracts, 
we have incubated the extracts from normal cells at 43 and 
46 “C for 2 h and supplemented them with the magnesium 
pellet fraction. Similarly to extracts from heat-shocked cells, 
heat-treated extracts lost their splicing activity (Fig. 2, lanes 
2 and 3). The splicing activity in the extract heated at 43 “C 
was poorly restored after supplementation with the magne- 
sium pellet fraction (Fig. 2, lane 5), as compared with reacti- 
vation of the extract from heat shocked cells (Fig. 2, lane 7). 
The activity in the extract heated at 46 “C was not restored 
at all (Fig. 2, lane 6). One interpretation of these results is 
that in vitro heating of the extract inactivates different splic- 
ing factors than in uiuo heat shock. Alternatively, the damage 
to splicing machinery may be more extensive and include the 
factor(s) inactivated by in vivo heat shock as well as additional 
splicing factors. 
It has been shown previously that incubation of nuclear 
extracts from normal cells at elevated temperatures inacti- 
vates splicing and that these extracts can be reactivated when 
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FIG. 2. Inactivation and reconstitution of splicing activity 
in extracts heated in LGO-o. Extracts from untreated cell\ were 
heated for 2 h at 43 and 46 ‘C and assayed for \pllcmg XIIVIIV alone 
(/unes 2 and 8, respectively) or after reconstitution with the magne- 
slum pellet fraction (/anc~s .j and f?. re\~)ect~\eivI. I,ar~p 1, control 
extract from untreated cells; /un(~ .I, ext& froi celts heat shocked 
at 43 ‘C: lane 7, same as Iun(~ 4, reconstituted with magnesium pellet 
upplemented with either S-100 (2,5) or certain fractions of 
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FIG. 1. A, effect of heat shock temperature on inactivation and 
reconstitution of sphcmg activity. Nuclear extracts from HeLa cells 
subjected to a 2-h heat shock at 40 (lanes 2 and J), 43 (lanes 4 and 
.5) and 46 ‘C (lanes 6 and 7) were assayed for splicmg activity with 
human @-globm pre-mRh’A as substrate as described under “Exper- 
imental Procedures.” In LaneA 3, 5, and 7 extracts were supplemented 
with the magnesium pellet fraction (JQP). Lune 1, control extract 
from untreated cells. Lane 8, magnesium pellet fraction. The RNA 
was analyzed on an 8% polyacrylarmde sequencmg gel. The structures 
of the input, intermediates, and products of splicmg are shown 
schematically on the left, their length in nucleotides on the r&t 
A,~terd denotes aherrant mohlhty of the lariat contaming products. 
B, time course of inactivatIon and reconstitution of splicing activity 
in extracts from cells subjected to heat shock at 43 ‘C. Nuclear 
extracts from HeLa cells heat-shocked at 43 ‘C for 30 mm (lanes 1 
nuclear extract from HeLa cells (28). To examine whether 
the factor(s) inactivated by in uiuo heat shock at 4Z ‘C are 
similar or different from previously identified thermolabile 
factors we have carried a complementation experiment. When 
an inactive extract, from cells heat shocked at 4:s ‘c for 2 h, 
was mixed with an equal amount of a nuclear extract inacti- 
vated by heating for 10 min at 45 ‘(Z (conditions used by 
Krainer and Maniatis, Ref. 25), the splicing activity of the 
extracts was restored (not shown). We conclude that different 
splicing factors were inactivated by these treatments. 
Characterization of the Damage to Splicing Machinery b3 
Heat Shock and Heat Treatment-Since snRNPs are involved 
in pre-mRNA splicing (29, SO), it seemed possible that these 
particles are damaged during heat shock. To analyze the 
changes in the structure and properties of the snRNPs, we 
have analyzed the nuclear extracts on nondenat,uring gels, in 
which snRNPs are presumably in a native state. Furthermore, 
the complex of U4, U5, and U6 snRNAs, shown to pre-exist 
in active splicing extracts (sl), can also be det,ected in these 
gels. The separated material was blotted onto a nylon mem- 
brane and hybridized with RNA probes for snRNAs. Fig. 3 
shows that the bands hybridizing to Ul and U2 RNA probes 
had the same mobility and intensity in control extracts and 
in those from cells heat shocked at 4Z ‘c, indicating that the 
structures of Ul and U2 snRNPs were not affected by this 
and 2), 1 h (lan<~,s ,Y and .I), 2 h (lc~n~s 5 and 6) Zj h (/MILKY 7 and 8). 
and 4 h (lune.s !? and 10) were assayed for splic& : ~7IctiviIv as described 
above. In bangs 2, 4, 6, X, and 10 the extracts bvere supplemented with 
a magnesium pellet fraction, C, recovery of splicin- c 1~ ‘ict ivi1.v after heat 
shock. HeLa cells heat-shocked at 43 “C were transferred to 37 ‘C. 
allowed to recover for 1, 2, 4, and 5 h, and the nuclear extracts were 
prepared immediately thereafter (/anus :I, ,l, 5, and 6, respectively). 
Splicing activity was assayed as above. I,O~IP /, control (C’) extract 
from untreated cells. Lam 2, extract f’rom cells alter heat shock CHS) 
without recovery at 37 ‘C. 
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FIG. 3. Analysis of snRNPs in extracts inactivated by in 
uiuo heat shock and in vitro heat treatment. Extracts were 
electrophoresed on nondenaturing polyacrylamide gels, and the sep- 
arated material was blotted onto nylon membrane and hybridized to 
“‘P-labeled RNA probes for U-snRNAs (see “Experimental Proce- 
dures”). The probes used are indicated at the top of the panels. 
Extracts from cells subjected to in viuo heat shock (denoted “shocked” 
in the figure) are shown in lanes 1-3, 7-9, and 13-15. In vitro heat- 
inactivated extracts from untreated cells (denoted “heated”) are 
shown in lanes 4-6, 10-12, and 16-18. The temperatures of the 
treatments are indicated at the top of the panels, the positions of Ul, 
U2, and U4. U5. U6 complexes are indicated on the left. 
treatment. (Fig. 3, lanes 2 and 8, respectively). In contrast, 
slowly migrating bands hybridizing to U4, U5, and U6 probes, 
representing the U4.U5.U6 snRNP complex (31), disap- 
peared after heat shock, whereas lower migrating bands re- 
mained visible (Fig. 3, lane 14, shows the results of hybridi- 
zation to U5 probe. Hybridizations with probes for U4 and 
U6 snRNAs are not shown, since they give essentially the 
same results). In the extract from cells subjected to heat shock 
at 46 “C, the U4.U5.U6 complex also disintegrated (Fig. 3, 
lane 15), and, in addition, the level of Ul and U2 snRNPs 
was decreased (Fig. 3, lane 3 and 9, respectively). 
We have also analyzed the snRNPs in the heat-inactivated 
nuclear extracts from normal cells. As in extracts from heat- 
shocked cells, Ul and U2 snRNPs were essentially unchanged 
in extracts heat-inactivated at 43 “C (Fig. 3, lanes 5 and 11), 
but their level was decreased at 46 “C! (Fig. 3, lanes 6 and 12), 
and the U4.U5. U6 snRNP complex disintegrated at both 
temperatures (Fig. 3, lanes 17 and 18, respectively). 
To determine if disintegration of U4 + U5 + U6 snRNP com- 
plex is accompanied by degradation of appropriate snRNAs, 
we have analyzed them on polyacrylamide sequencing gels 
stained with silver (Fig. 4). The snRNAs were identified on 
the basis of their gel mobility and by comparison with blots 
of similar gels hybridized with RNA probes for snRNAs. The 
results show that the pattern of stained snRNAs is very 
similar under all treatment conditions and is not different 
from that for control extract. Since neither heat shock nor 
heat inactivation of the extracts led to degradation of sn- 
RNAs, one can conclude that the snRNAs are protected by 
snRNP proteins from nucleases present in the extract and 
that at least partial integrity of the snRNPs is retained after 
these treatments. This is further supported by the fact that 
all species of snRNAs are present in the anti-Sm immunopre- 
cipitates of nuclear extracts from heat-shocked cells labeled 
in vivo with 32P (results not shown). 
If heat shock at 43 “C causes only a limited damage to 
splicing factors, it seemed possible that the formation of 
splicing complexes, the spliceosomes (32-34), would be im- 
paired only to a limited extent. We have carried out the 
analysis of spliceosome formation on nondenaturing poly- 
acrylamide gels which resolve three splicing complexes, cy, p, 
and y (22). We found that during splicing reaction with 
nuclear extracts from cells heat-shocked at 43 “C, only inter- 
mediate splicing complexes LY and p were formed, but the 
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FIG. 4. Analysis of snRNAs in extracts inactivated by in 
viuo heat shock and in vitro heat treatment. All extracts were 
adjusted with buffer D to the same protein concentration and the 
aliquots extracted with phenol and electrophoresed on 12.5% poly- 
acrylamide sequencing gel. RNA from 3 ~1 of each extract was loaded 
per lane. The temperatures of in uiuo heat shock or in vitro heat 
treatment are shown at the top. Positions of snRNAs are indicated 
on the left. 
CONTROL HEAT SHOCK 







FIG. 5. Spliceosome formation by extracts from cells heat- 
shocked at 43 ‘C. 1-~1 aliquots from standard splicing reactions 
were electrophoresed on 3.8% nondenaturing polyacrylamide gels (see 
“Experimental Procedures”), and the gels were autoradiographed. 
Lanes I-3, control extract from untreated cells; lanes 4-6, extract 
from cells subjected to heat shock at 43 “C. Aliquots were withdrawn 
from the splicing reaction at 0 (lanes 1 and 4), 20 (lanes 2 and 5), 
and 40 min (lanes 3 and 6). Positions of o(, 0, and y complexes are 
shown on the left. Z denotes a nonspecific RNA-protein complex. 
functional spliceosome, complex y, was not (Fig. 5, lanes 5 
and 6). The mobility of the (Y and /3 complexes formed with 
extract from heat-shocked cells is identical to that of the 
complexes in the normal extract (Fig. 5, lanes 2 and 3). This 
suggests that splicing factors required for the formation of 
complexes (Y and @ remain functional and are not damaged by 
heat shock at 43 “C. 
Purification of the Splicing Factor Inactivated by Heat 
Shock-To characterize the factor inactivated by heat shock 
at 43 “C, we have subjected a nuclear extract from cells grown 
under standard conditions to a purification protocol which 
included the following steps: dialysis of the extract against 
buffer D containing 12.5 mM MgClz and high speed centrifu- 
gation of the resulting precipitate, chromatography of the 
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pelleted material on fast protein liquid chromatography Mono 
Q column eluted stepwise with 0.5 M KCl, and subsequent 
chromatography of the eluted material on the same column 
developed with a salt gradient (0.1-0.5 M KCl). The details of 
purification are described under “Experimental Procedures.” 
The purified fractions were assayed for their ability to rescue 
splicing activity of the nuclear extract from HeLa cells sub- 
jected to in uiuo heat shock for 2 h at 43 “C (Fig. 6A). In 
parallel, the snRNA content of the chromatographic fractions 
was assayed by analyzing their phenol-extracted aliquots on 
silver-stained polyacrylamide gels (Fig. 6B). The rescuing 
activity precipitated into the magnesium pellet after dialysis 
against magnesium containing buffer and centrifugation (Fig. 
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FIG. 6. A, fractionation of factor(s) inactivated by heat shock. 
Extract from normal untreated cells was fractionated according to 
purification protocol described under “Experimental Procedures” and 
used to reconstitute splicing activity in extract from cells heat shocked 
at 43 “C. lo-12 ~1 of extract from heat-shocked cells was supple- 
mented with 3-5 ~1 of purified fractions and assayed for splicing 
activity. Concentration of all added fractions was adjusted to equal 
amount of protein. Products and intermediates of splicing reaction 
were assayed on 8% polyacrylamide sequencing gel as in Fig. 1. 
Fractions used for supplementation were: lane 1, buffer as control; 
lane 2, magnesium pellet; lane 3, material eluted during stepwise 
elution of the Mono Q column at 0.5 M KCl. Lanes 4-10, material 
eluted during gradient elution of Mono Q column, fractions assayed 
are indicated at the top of the figure. B, analysis of snRNA content 
in purified fractions. Fractions from the last step of purification 
(gradient elution of Mono Q column) were phenol-extracted, and the 
RNA was analyzed on 12.8% polyacrylamide sequencing gel stained 
with silver. Lane 1, RNA from 3 ~1 of normal control extract. Lanes 
2-8, 3-5 ~1 of fractions from Mono Q column as indicated at the top 
of the figure. 
FIG. 7. Micrococcal nuclease treatment of purified frac- 
tions. Magnesium pellet and fraction IV from Mono Q column were 
treated with micrococcal nuclease (600 units/ml) as described under 
“Experimental Procedures.” Treated fractions were used to rescue 
nuclear extract from cells heat-shocked at 43 “C. Fractions used for 
supplementation were: lane I, buffer as control; lane 2, magnesium 
pellet-treated micrococcal nuclease; lane 3, untreated magnesium 
pellet; lane 4, fraction IV treated with micrococcal nuclease; lane 5, 
untreated fraction IV. 
proteins which remained in the supernatant. Most of the 
snRNPs were also precipitated during this procedure (not 
shown). The material from the magnesium pellet was further 
purified by chromatography on fast protein liquid chromatog- 
raphy Mono Q column. During stepwise elution the rescuing 
activity came off the column at 0.5 M KC1 (Fig. 6A, lane 3). 
In the subsequent chromatographic step, during elution of 
Mono Q column with a salt gradient from 0.1 to 0.5 M KCl, 
the activity was eluted at approximately 0.3 M KCl. Attempts 
of further purification were unsuccessful as the rescuing ac- 
tivity was inactivated during chromatography on ATP-Seph- 
arose, single-stranded DNA-Sepharose, and phenyl-sepha- 
rose. 
In contrast to initial steps of purification, the purest active 
fraction (fraction IV, Fig. 6A, lane 8) was essentially devoid 
of snRNAs (Fig. 6B, lane 6) and separated from the bulk of 
snRNPs, which were eluted at higher salt concentrations. 
This result suggested that the rescuing activity is a protein. 
Additional experiments to support this observation were car- 
ried out. The rescuing activity in fraction IV from Mono Q 
column and in the magnesium pellet was resistant to treat- 
ment with micrococcal nuclease at a concentration of 600 
units/ml (Fig. 7). This concentration of the nuclease is at 
least six times higher than that needed to inactivate splicing 
in nuclear extracts. Moreover, an RNA free fraction of the 
nuclear extract or magnesium pellet obtained by chromatog- 
raphy on DE-53 anion exchange column as described by 
Pikielny et al. (35) was also able to rescue the activity of the 
nuclear extract from cells heat-shocked at 43 “C. Finally, the 
addition of fractions containing snRNPs (fractions V and VI 
from Mono Q column, Fig. 6A, lanes 7 and 8) to fraction IV 
did not increase its ability to reactivate splicing (data not 
shown). Thus, by these criteria, the factor inactivated by heat 
shock at 43 “C appears to be a protein and not an snRNP. 
Since, as we have shown above, heat shock also affects the 
structure of the U4. U5. U6 snRNP complex and prevents 
formation of the splicing complex y, it appears that the 
inactivated factor is essential for the integrity of both of these 
complexes. 
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DISCUSSION 
It has been reported in a series of recent papers (7, 14-18) 
that mRNA metabolism is affected by heat shock or other 
stress conditions. In most cases the rate of transcription was 
not inhibited but the level of newly synthesized mRNA in the 
cytoplasm decreased with a concomitant accumulation of pre- 
mRNA in the nucleus, suggesting a defect in either splicing 
or transport of the mRNA to the cytoplasm. In fact, in vivo 
splicing of hsp pre-mRNAs containing introns was inhibited 
during heat shock of Drosophila Shneider cells (l&16), mouse 
cells (17), and HeLa cells (18). Inhibition of splicing of other 
pre-mRNAs such as ubiquitin (7) was also observed. We have 
found that nuclear extracts prepared from HeLa cells sub- 
jected to heat shock exhibit a significant decrease of splicing 
activity and that this decrease is due to inactivation of specific 
splicing factor(s). Thus it appears that an important defect 
in mRNA metabolism during heat shock is due to inactivation 
of a component of the splicing apparatus. 
Several lines of evidence show that the damage to splicing 
due to heat shock at 43 “C is limited and specific. Splicing 
activity could be reconstituted by purified fractions only in 
extracts from cells heat-shocked at 43 “C. Ul and U2 snRNPs 
were not affected by the treatment and, in spite of the disin- 
tegration of the U4. U.5. U6 snRNP complex, U4, U5, and U6 
snRNAs remained intact in the extract. The latter finding, as 
well as immunoprecipitation experiments, suggest that these 
snRNAs are still protected by snRNP specific proteins. The 
remaining U4, U5, and U6 snRNP complexes are functional 
to the extent that the extract from cells heat shocked at 43 “C 
could form apparently normal splicing complexes LY and p. It 
has been shown that these complexes contain other splicing 
factors (36, 37) in addition to snRNPs (31). Thus, all these 
factors retain the capability to form the cy and /3 complexes 
after heat shock at 43 “C, underscoring a limited nature of 
the damage under these conditions. One can also conclude 
from these results that the factor inactivated by heat shock 
at 43 “C is different from those required for formation of the 
LY and p complexes. Another interpretation of the data shown 
in Fig. 5 is that the factor is required for formation of all 
three complexes but, due to its partial inactivation during 
heat shock, formation of the complexes is slower, so that the 
complex y is not yet detectable on the gel. 
Purification of the factor and reactivation of splicing in 
extracts from heat-shocked cells with fractions free of RNA 
strongly suggest that the activity damaged by heat shock at 
43 “C is a protein. Although final proof will require purifica- 
tion of the factor to homogeneity, a most likely interpretation 
of the experiments presented above is that the factor inacti- 
vated by heat shock of HeLa cells at 43 “C is a protein that 
interacts with an snRNP complex composed of U4, U5, and 
U6 snRNPs. This protein is apparently essential to maintain 
the integrity of the complex as well as for the formation of 
the functional spliceosome. Further support for this observa- 
tion is provided by the fact that addition of the fraction 
purified through Mono Q column, to the extract from cells 
heat-shocked at 43 “C was able to restore to some extent the 
formation of the complex y during splicing reaction (not 
shown). 
The damage of the splicing factors during heat shock at 
46 “C or during heating of the normal extracts at 43 or 46 “C 
is more extensive. This is seen in the fact that in addition to 
disintegration of U4. U5. U6 snRNP complex, these treat- 
ments lead to decreased levels of Ul and U2 snRNP and an 
inability of these extracts to be reconstituted by the magne- 
sium pellet fraction. One likely possibility for heat-treated 
extracts is that during 2-h incubation at elevated tempera- 
tures proteolytic and/or nucleolytic degradation of a number 
of splicing factors contributes to inactivation of splicing. 
It has been shown previously that incubation of the extract 
at 45 “C for 10 min (Ref. 25) or at 37 “C for 40 min (Ref. 38) 
inhibits only a second step of the splicing reaction, i.e. cleav- 
age at the 3’ splice site end exon ligation, without affecting 
the first step, cleavage at the 5’ splice site and lariat forma- 
tion. Furthermore, the latter conditions allowed for the for- 
mation of the complex y. This is in contrast to inactivation 
during heat shock at 43 “C where complex y formation and 
therefore the first step of splicing are inhibited. Thus it 
appears that heating of the extracts at milder conditions leads 
to inactivation of a factor different from that inactivated by 
heat shock of the cells at 43 “C. Since none of the factors in 
question (25,28,38) are purified to homogeneity, these results 
should be interpreted with caution. 
Heat shock response is elicited by a variety of chemicals in 
addition to heat (l-3, 39, 40). We have tested whether such 
treatments would also inactivate splicing. Surprisingly, we 
found that nuclear extracts from HeLa cells treated with 
sodium arsenite and sulfates of zinc, cadmium, and copper 
retained full splicing activity. These salts were used in con- 
centrations which induced synthesis of heat shock proteins, 
as assayed by dot blot analysis using a cDNA probe for hsp 
70 or by incorporation of [3H]leucine into heat shock proteins 
(not shown). We interpret these results to mean that the 
factor inactivated by heat shock is thermolabile but not sus- 
ceptible to other stress conditions. Since accumulation of 
nuclear RNA coded by heat shock genes containing introns 
was observed in vivo after sodium arsenite treatment of HeLa 
cells (18), it appears that in vivo inhibition of splicing and/or 
transport of mature mRNA to the cytoplasm can also be 
achieved by a mechanism different than the inactivation of a 
thermolabile splicing factor. 
While this work was in progress Ursula Bond reported the 
effects of heat shock on in vitro splicing of adenovirus pre- 
mRNA (18). This author also noted the disintegration of U4. 
U5. U6 snRNP complex, and, in contrast to our results, dam- 
age to U2 snRNP and aberrant formation of splicing com- 
plexes were also observed. This discrepancy is probably due 
to the difference in temperature during heat shock, since in 
that work nuclear extracts from cells heat-shocked at 45 “C 
were studied. As pointed out previously at this temperature a 
more extensive damage to the components of splicing machin- 
ery could be expected. In support of our observations, Bond 
also noted that heat shock appears to damage a factor differ- 
ent from a thermolabile factor identified by Krainer and 
Maniatis (25). 
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